{"ticker": {"uuid": "fd214e56-75e4-480a-971a-955f244e1ad3", "symbol": "SVNS", "name": "Solvonis Therapeutics plc", "exchange": "LSE", "country": "GB", "sector": "Industrials", "industry": "Specialty Industrial Machinery"}, "articles": [{"title": "Why Solvonis Therapeutics (LSE:SVNS) Is Drawing Fresh Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaVdNMzhlbXc2ZjZJRzlIeDk2Ym1XcmVpMkVIOHA1SlMwQjBwNS1jUEFNZGRfYjd4YTRlcm0wblRZaFZSQmRPNnRCRGNublpkbVF3dmJ0bV9jemhLdEVvSHlUclFpcnFSOWZRM0h4Zm1jaGdlXzdJamNRYVE0WjhtRFVDOVN2cFNlRzM0WDNCZVN4TEx5bVh0OFdQZmFMWE5jRnBtVlVSLUdydw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T11:07:00+00:00", "published_display": "13 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US Research house initiates Solvonis coverage citing differentiated addiction strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOMWFPQzdBX2twWGx2Wnhwd1BaV29QWVhjMW9BZUFzREVCT09GVldwb2NvaVhvWVh6dk9kSWY5ZGZ0UFFfWGswMV9QdHQ3eVMwSmQ2R2tYTkc5NDloT2hXX3FwcTFUdWV3aS1RQVlOVS1xbUVveDVqVTBTTnNHZGtuWjZ3Z3RaeV9kUU5RSWRn?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-13T09:10:00+00:00", "published_display": "13 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics Gains (LSE:SVNS) US Spotlight as Clinical Pipeline Advances", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxORnA5NENuMWNZZlQ0WjNiaW1SeUVyZDZ6Q2tScDFlZWZELXViZDU2RFotaHowbXhLdWxCeHN5akplc3M5TlA2aU5hRkJUN1FaOGF1NDBWcVRpT1BOVUNtX2lFUWFRbDhTSEh5amk0Y1AyZTd2QWttYzctSEw5NEd5Yll3OG9udTNubGRGWC1iUVpHdTFITjd0aWxtUFp0aV9od19MeDFQdzdxSEhOMHNwLWJGT1oyaVlnM3dQdXQ0UGg?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T08:24:00+00:00", "published_display": "13 Jul 2026 08:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis shares up 12% after clears key hurdle in bid to treat alcohol addiction with esketamine treatment - UPDATE", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxQaENkbTVaVklGMHJIQkRzRkJDOVFHZEdwS0lWYzNaeFlnSUd3QUhLeE56eDhiOGhyMnpOX2ozakN1aXM5a2VoOU1iRklfS09XX1gza2J1ZzZKMmJfdTF1NkdzZTNJelJLS1hiNkNvQXNVaHlydmQ4cVVMd2RCZFRHbHZCV3RPUnZ2YmFFbXgycXdhUzNwWjdaeXhwX1ZIVWVqOFVPaDFOVzJHTm5KVVJITkR4ZzdwaEFfRS1JS3FRNEZpbl9HN0tlcWRoaDVJVVV6LTRxY2t0Wlh4VTA2M2N0M24xemlEb1dLVGZ3Rm1CY0ZQT2MzcnpEYTA0VDA1aUowYko1STJXbHBzdGNtMUJycnFmQQ?oc=5", "source_name": "Proactive Investors", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics refines strategy around SVN-001 phase III value inflexion point", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQaGxwcDY0S2pMYUU1ZnJuYTF0cGNsdm5CeldybHlPU1B1SmJVU1BCZ0h0ZnU4NVA0MWF4c3VQTVFNcXZxVmU4M3ZDRXpTZHU0eEVjRGNLZ2FEajNzeVJWaE5TNlVNcjlubXhFbXRXYTBHR1dGUXJfVjlqTnRZcWdDSkRIeE9GeXV0TU1aWFFlRXFzNmtXR3RVQVp3?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Therapeutics - Small Cap Snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNYzh0MG9DQXZ6VnYxOUFzbWdLcVljcHAtVnVfLVNhLXJJZ1JDYzREdnFZNlgwX1Eyc3g3WWJDb3F1YTZ2alc1NUZGTlc4Z0tBY0xSMTF2dXg4Rlh1QWVkM18wblh1RXJrRGxPYS1YeGRpRXNESm9PRER6YTZlaG5TNkw3bFhBUk9xc0I5bWs2R2RaZ2ZlUTVvdkpGdi1GR0Jfc3lqQVlWcnBnV2VxZm50Zzl3N0ttdE1qMmIyWElsRVMtZ2F0WUNrMXlrYUlFbGl5emhMdFNveWFQaFRPVC0zdS1JdWt2T3JtWEE?oc=5", "source_name": "Proactive Investors", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPNXdKLWt5a3YxRF9ad2xSM2VKUnV2alNJaXdROWd0Wm9IVWRacHM1V0dVYy1TVTRDUWV4dGpyQldBMDVYRTk4a295N1VvSVNEVUhXbGdkZkxtQnlHMzlwQ1lFY0w1MGdkTVdXVFR2V2ZLLXFYQU5pRmRQQkUtenpxdnNQUWpzV25UNE9TTV9HWGYyWGZXTVRqNTRPVTllNnZhU05DR0R3UXdNV2Q2M1ZZYkxlOXQ1WEJUbGhCdS1NMWdIWExfMGV2OGRvYjZ3RFJWVVhyYmpZdVk0UTNONnlNRWxJUlNfU2c?oc=5", "source_name": "Proactive Investors", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis raises \u00a31 million from top investors to accelerate AI drug discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQX1RMWXhmRjlfM0NmZ25IaUFoYXRoMHB5TE1mYWR1bVdhNEprbE5QSjR5cTBPcU5oLTVwMzF4YVdIRk85NzYzNnlFd1VvTkwyb3NFZFNaM3JYcko4c0QtckE0cFFweW9wRmxrVnpzM09WN1lXUjl2WjJCMks0NktqYzdta3NlWHVsOF9fZllXTllNLVVzaVlNT2loU3BONjUzSEllQmVtdlBiT0ZWc1ZYSWstN2kzVUtmMWVXVEw1WlhwU25IcHNVVm1INFM0OEpyVERwck5vOWl1enVEVG82RXdOTDk?oc=5", "source_name": "Proactive financial news", "published_at": "2025-07-11T07:00:00+00:00", "published_display": "11 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeV9BWmJzX2Z4SlFlZjlCSkVkSWJrTHRSaXlhM2YwbXRycWJvMG9ObGpyRWc1d2xTX0NibDZuWDkydXVNb2RVTmlPOXRNRWRHd2paUkNzSF9ZTTNTX1BzYURXWm1PdmdGaWJfY1d0b1JNWmF1YmlGWUVaeVA2S05hd3RyYVhGZjRIMTRjTlBvR2Joc2dSUzdRVnV1TTRvX0JXTDI5R2lhUTRMeEdsb25heEFNQ3FmNnNjb0VQX25jUjAxa0RwaTNmZ21BMVhHc3BqUjJn?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-05-27T07:00:00+00:00", "published_display": "27 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics PLC Share Price - SVNS, RNS News, Articles, Quotes, & Charts (LON:SVNS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFAwcDgzN2t0V0tMMmFWZXk1Y21EaFdGRVl3WW9PX3dCYlFnVkdIeVJndFFBZVhCczVESDhZa2JQRFdLSmQ5SVhEOU96TWJiLVlLNlF5WWFHWXpHTWZJclZhdGRhOFRzUzZBbmJ3TEJTT1hrMWR3SDRiQkFSUm4?oc=5", "source_name": "Proactive financial news", "published_at": "2025-01-20T07:31:31+00:00", "published_display": "20 Jan 2025 07:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SVNS Stock Price and Chart \u2014 LSE:SVNS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1hbmdKVVZpNW1nT0NQUWZZdmxqQU1NQmRUZndra3pHSEc3TWtvT2NEQjl3dk5mcjg5anI5ai02Uy1qNU9TYVpPQW8zbXhieFRlZ1JpMEpSckU?oc=5", "source_name": "TradingView", "published_at": "2025-01-15T13:19:01+00:00", "published_display": "15 Jan 2025 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therap Live Share Prices and Trades. SVNS Live Streaming Share Prices.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQl9UalZ3SzMtOWRwVmRRSGxDTG5uZEVPWWNGcm1QRzBIRW9HN3BuY19rRzU5SWF3YXY1Z0w1T3V5aWd0b2Frc3lsMXlYVjNybVFDajI3NG1TYkQ3eGxESVJzVDdLa3RFQ3h1LWY3QmQybHlrTVdRMGY2NVp2cWFLMy0zTHJ3Zw?oc=5", "source_name": "London South East", "published_at": "2025-01-15T11:05:00+00:00", "published_display": "15 Jan 2025 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Solvonis Therapeutics (LSE:SVNS) Is Drawing Fresh Attention", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaVdNMzhlbXc2ZjZJRzlIeDk2Ym1XcmVpMkVIOHA1SlMwQjBwNS1jUEFNZGRfYjd4YTRlcm0wblRZaFZSQmRPNnRCRGNublpkbVF3dmJ0bV9jemhLdEVvSHlUclFpcnFSOWZRM0h4Zm1jaGdlXzdJamNRYVE0WjhtRFVDOVN2cFNlRzM0WDNCZVN4TEx5bVh0OFdQZmFMWE5jRnBtVlVSLUdydw?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T11:07:00+00:00", "published_display": "13 Jul 2026 11:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US Research house initiates Solvonis coverage citing differentiated addiction strategy", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOMWFPQzdBX2twWGx2Wnhwd1BaV29QWVhjMW9BZUFzREVCT09GVldwb2NvaVhvWVh6dk9kSWY5ZGZ0UFFfWGswMV9QdHQ3eVMwSmQ2R2tYTkc5NDloT2hXX3FwcTFUdWV3aS1RQVlOVS1xbUVveDVqVTBTTnNHZGtuWjZ3Z3RaeV9kUU5RSWRn?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-13T09:10:00+00:00", "published_display": "13 Jul 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics Gains (LSE:SVNS) US Spotlight as Clinical Pipeline Advances", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxORnA5NENuMWNZZlQ0WjNiaW1SeUVyZDZ6Q2tScDFlZWZELXViZDU2RFotaHowbXhLdWxCeHN5akplc3M5TlA2aU5hRkJUN1FaOGF1NDBWcVRpT1BOVUNtX2lFUWFRbDhTSEh5amk0Y1AyZTd2QWttYzctSEw5NEd5Yll3OG9udTNubGRGWC1iUVpHdTFITjd0aWxtUFp0aV9od19MeDFQdzdxSEhOMHNwLWJGT1oyaVlnM3dQdXQ0UGg?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T08:24:00+00:00", "published_display": "13 Jul 2026 08:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis shares up 12% after clears key hurdle in bid to treat alcohol addiction with esketamine treatment - UPDATE", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxQaENkbTVaVklGMHJIQkRzRkJDOVFHZEdwS0lWYzNaeFlnSUd3QUhLeE56eDhiOGhyMnpOX2ozakN1aXM5a2VoOU1iRklfS09XX1gza2J1ZzZKMmJfdTF1NkdzZTNJelJLS1hiNkNvQXNVaHlydmQ4cVVMd2RCZFRHbHZCV3RPUnZ2YmFFbXgycXdhUzNwWjdaeXhwX1ZIVWVqOFVPaDFOVzJHTm5KVVJITkR4ZzdwaEFfRS1JS3FRNEZpbl9HN0tlcWRoaDVJVVV6LTRxY2t0Wlh4VTA2M2N0M24xemlEb1dLVGZ3Rm1CY0ZQT2MzcnpEYTA0VDA1aUowYko1STJXbHBzdGNtMUJycnFmQQ?oc=5", "source_name": "Proactive Investors", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics refines strategy around SVN-001 phase III value inflexion point", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQaGxwcDY0S2pMYUU1ZnJuYTF0cGNsdm5CeldybHlPU1B1SmJVU1BCZ0h0ZnU4NVA0MWF4c3VQTVFNcXZxVmU4M3ZDRXpTZHU0eEVjRGNLZ2FEajNzeVJWaE5TNlVNcjlubXhFbXRXYTBHR1dGUXJfVjlqTnRZcWdDSkRIeE9GeXV0TU1aWFFlRXFzNmtXR3RVQVp3?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "hVIVO, Rift Helium, Galliford Try, Valereum, accesso, Solvonis Therapeutics - Small Cap Snapshot", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNYzh0MG9DQXZ6VnYxOUFzbWdLcVljcHAtVnVfLVNhLXJJZ1JDYzREdnFZNlgwX1Eyc3g3WWJDb3F1YTZ2alc1NUZGTlc4Z0tBY0xSMTF2dXg4Rlh1QWVkM18wblh1RXJrRGxPYS1YeGRpRXNESm9PRER6YTZlaG5TNkw3bFhBUk9xc0I5bWs2R2RaZ2ZlUTVvdkpGdi1GR0Jfc3lqQVlWcnBnV2VxZm50Zzl3N0ttdE1qMmIyWElsRVMtZ2F0WUNrMXlrYUlFbGl5emhMdFNveWFQaFRPVC0zdS1JdWt2T3JtWEE?oc=5", "source_name": "Proactive Investors", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPNXdKLWt5a3YxRF9ad2xSM2VKUnV2alNJaXdROWd0Wm9IVWRacHM1V0dVYy1TVTRDUWV4dGpyQldBMDVYRTk4a295N1VvSVNEVUhXbGdkZkxtQnlHMzlwQ1lFY0w1MGdkTVdXVFR2V2ZLLXFYQU5pRmRQQkUtenpxdnNQUWpzV25UNE9TTV9HWGYyWGZXTVRqNTRPVTllNnZhU05DR0R3UXdNV2Q2M1ZZYkxlOXQ1WEJUbGhCdS1NMWdIWExfMGV2OGRvYjZ3RFJWVVhyYmpZdVk0UTNONnlNRWxJUlNfU2c?oc=5", "source_name": "Proactive Investors", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis raises \u00a31 million from top investors to accelerate AI drug discovery", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQX1RMWXhmRjlfM0NmZ25IaUFoYXRoMHB5TE1mYWR1bVdhNEprbE5QSjR5cTBPcU5oLTVwMzF4YVdIRk85NzYzNnlFd1VvTkwyb3NFZFNaM3JYcko4c0QtckE0cFFweW9wRmxrVnpzM09WN1lXUjl2WjJCMks0NktqYzdta3NlWHVsOF9fZllXTllNLVVzaVlNT2loU3BONjUzSEllQmVtdlBiT0ZWc1ZYSWstN2kzVUtmMWVXVEw1WlhwU25IcHNVVm1INFM0OEpyVERwck5vOWl1enVEVG82RXdOTDk?oc=5", "source_name": "Proactive financial news", "published_at": "2025-07-11T07:00:00+00:00", "published_display": "11 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Awakn Life Sciences Announces Completion of Arrangement and Sale to Solvonis Therapeutics plc", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeV9BWmJzX2Z4SlFlZjlCSkVkSWJrTHRSaXlhM2YwbXRycWJvMG9ObGpyRWc1d2xTX0NibDZuWDkydXVNb2RVTmlPOXRNRWRHd2paUkNzSF9ZTTNTX1BzYURXWm1PdmdGaWJfY1d0b1JNWmF1YmlGWUVaeVA2S05hd3RyYVhGZjRIMTRjTlBvR2Joc2dSUzdRVnV1TTRvX0JXTDI5R2lhUTRMeEdsb25heEFNQ3FmNnNjb0VQX25jUjAxa0RwaTNmZ21BMVhHc3BqUjJn?oc=5", "source_name": "TMX Newsfile", "published_at": "2025-05-27T07:00:00+00:00", "published_display": "27 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therapeutics PLC Share Price - SVNS, RNS News, Articles, Quotes, & Charts (LON:SVNS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFAwcDgzN2t0V0tMMmFWZXk1Y21EaFdGRVl3WW9PX3dCYlFnVkdIeVJndFFBZVhCczVESDhZa2JQRFdLSmQ5SVhEOU96TWJiLVlLNlF5WWFHWXpHTWZJclZhdGRhOFRzUzZBbmJ3TEJTT1hrMWR3SDRiQkFSUm4?oc=5", "source_name": "Proactive financial news", "published_at": "2025-01-20T07:31:31+00:00", "published_display": "20 Jan 2025 07:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SVNS Stock Price and Chart \u2014 LSE:SVNS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1hbmdKVVZpNW1nT0NQUWZZdmxqQU1NQmRUZndra3pHSEc3TWtvT2NEQjl3dk5mcjg5anI5ai02Uy1qNU9TYVpPQW8zbXhieFRlZ1JpMEpSckU?oc=5", "source_name": "TradingView", "published_at": "2025-01-15T13:19:01+00:00", "published_display": "15 Jan 2025 13:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Solvonis Therap Live Share Prices and Trades. SVNS Live Streaming Share Prices.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOQl9UalZ3SzMtOWRwVmRRSGxDTG5uZEVPWWNGcm1QRzBIRW9HN3BuY19rRzU5SWF3YXY1Z0w1T3V5aWd0b2Frc3lsMXlYVjNybVFDajI3NG1TYkQ3eGxESVJzVDdLa3RFQ3h1LWY3QmQybHlrTVdRMGY2NVp2cWFLMy0zTHJ3Zw?oc=5", "source_name": "London South East", "published_at": "2025-01-15T11:05:00+00:00", "published_display": "15 Jan 2025 11:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 12, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 10, "score": 53, "total": 12, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 95, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.0, "latest_week": "2026-07-10", "one_week_move": -3.6, "four_week_move": -21.0, "twelve_week_move": -42.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.501192, "market_dynamics_buy_signal": false, "relative_strength": -44.208873, "fair_value_gap": -67.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.8258, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.6% over one week, -21.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Proactive Investors", "count": 3}, {"label": "Kalkine Media", "count": 2}, {"label": "Proactive financial news", "count": 2}, {"label": "Yahoo! Finance Canada", "count": 1}, {"label": "Market source", "count": 1}, {"label": "TMX Newsfile", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "London South East", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 12}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "95/100 classification confidence."}, {"label": "Company focus", "value": "12", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.6% over one week, -21.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Solvonis Therapeutics (LSE:SVNS) Is Drawing Fresh Attention"}], "updated_at": "2026-07-17T09:16:56.918839+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}